{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["harm of herbs", "hypermelanosis", "safety of medicinal plants", "skin diseases", "vitiligo"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33790609", "DateRevised": {"Year": "2024", "Month": "03", "Day": "31"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "03", "Day": "23"}], "Language": ["eng"], "ELocationID": ["10.2147/CCID.S298342"], "Journal": {"ISSN": "1178-7015", "JournalIssue": {"Volume": "14", "PubDate": {"Year": "2021"}}, "Title": "Clinical, cosmetic and investigational dermatology", "ISOAbbreviation": "Clin Cosmet Investig Dermatol"}, "ArticleTitle": "The Safety of Medicinal Plants Used in the Treatment of Vitiligo and Hypermelanosis: A Systematic Review of Use and Reports of Harm.", "Pagination": {"StartPage": "261", "EndPage": "284", "MedlinePgn": "261-284"}, "Abstract": {"AbstractText": ["Vitiligo is disfiguring and devastating condition that can humans feel stigmatic and devalued. Melasma is a general condition of hyperpigmentation particularly involving the face. The pigmentation disorders of vitiligo (hypopigmentation or de-pigmentation) and melasma (Hypermelanosis) are common among the world's population (around 1% for vitiligo).", "The identification of medicinal plants used in the treatment of vitiligo and hypermelanosis. A systematic literature review on harms associated with the medicinal plants used in the treatment of vitiligo and hypermelanosis. To review and summarize information on reported adverse drug reactions (ADRs) associated with these medicinal plants contained in (where access is available) national and global individual case safety report databases.", "A systematic review of the literature with special reference to all types of clinical trial and case reports using biomedical databases including Medline, EMBASE, Scopus, International Pharmaceutical Abstracts and so forth to identify medicinal plants alone or as an adjuvant with other treatments and their safety/tolerability in the treatment of vitiligo and Hypermelanosis. Other sources of this search were medicinal plants text books, pharmacopoeias and authentic websites discussing possible treatments for vitiligo/hypermelanosis. It also included databases such as VigiAccess containing data from spontaneous reporting schemes for ADRs.", "A total of 55 articles (47 clinical trials and 8 case reports) met the inclusion criteria. Some trials did not reported safety information, some did report, but not very well. Reports of blistering, erythema, acute hepatitis and mutagenesis with <i>Psoralea corylifolia</i>. Adverse effects of erythema (mild to severe), phototoxic reactions, mild raise in liver transaminases, gastrointestinal disturbances, burns, itching, scaling, depigmented macules, pruritis, and giddiness with the use of psoralens. Khellin-related erythema, perilesional hyperpigmentation, gastrointestinal disturbances, mild raise in liver transaminases and orthostatic complaints. Infrequent side effects with Ginkgo biloba. Lower grade of erythema and edema reported with the use of <i>Polypodium leucotomos.</i>", "Primarily the retrieved clinical studies were efficacy oriented and safety parameters were secondary in priority whilst the general protocol of clinical trials requires the screening of drugs/medicinal plants on the basis of safety studies before testing the clinical aspects of efficacy. Thereby it is recommended that efficacy studies may be followed once the safety has been established for a particular medicinal plant in treating vitiligo and hypermelanosis."], "CopyrightInformation": "\u00a9 2021 Hussain."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Pharmacy, Shaheed Mohtarma Benazir Bhutto (SMBB) Medical University, Larkana, Pakistan."}], "LastName": "Hussain", "ForeName": "Irshad", "Initials": "I"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "New Zealand", "MedlineTA": "Clin Cosmet Investig Dermatol", "NlmUniqueID": "101543449", "ISSNLinking": "1178-7015"}, "CoiStatement": "The author reports no conflicts of interest for this work. A part of this article was made available as pre-print on research gate and will be updated accordingly once published in the journal."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Khandalavala BN, Nirmalraj MC. Rapid partial repigmentation of vitiligo in a young female adult with a gluten-free diet. Clin Dermatol. 2014;6(3):283\u2013287.", "ArticleIdList": ["PMC4307007", "25685131"]}, {"Citation": "Torok HM. A comprehensive review of the long-term and short-term treatment of melasma with a triple combination cream. Am J Clin Dermatol. 2006;7:223\u2013230. doi:10.2165/00128071-200607040-00003", "ArticleIdList": ["10.2165/00128071-200607040-00003", "16901182"]}, {"Citation": "Khushboo PS, Jadhav VM, Kadam VJ, et al. Psoralea corylifolia linn. \u2013 \u201ckushtanashini\u201d. Pharmacogn Rev. 2010;4(7):69\u201376. doi:10.4103/0973-7847.65331", "ArticleIdList": ["10.4103/0973-7847.65331", "PMC3249905", "22228944"]}, {"Citation": "Szczurko O, Born HS. A systematic review of natural health product treatment for vitiligo. BMC Dermatol. 2008;8:2. doi:10.1186/1471-5945-8-2", "ArticleIdList": ["10.1186/1471-5945-8-2", "PMC2432048", "18498646"]}, {"Citation": "Fisk WA, Agbai O, Lev-Tov HA, Sivamani RK. The use of botanically derived agents for hyperpigmentation: a systematic review. J Am Acad Dermatol. 2014;70(2):352\u2013365. doi:10.1016/j.jaad.2013.09.048", "ArticleIdList": ["10.1016/j.jaad.2013.09.048", "24280646"]}, {"Citation": "Ekor M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol. 2013;4:177.", "ArticleIdList": ["PMC3887317", "24454289"]}, {"Citation": "Masoumeh G, Ali E. Clinical efficacy of liposome-encapsulated Aloe vera on melasma treatment during pregnancy. J Cosmet Laser Ther. 2017;19(3):181\u2013187. doi:10.1080/14764172.2017.1279329", "ArticleIdList": ["10.1080/14764172.2017.1279329", "28139161"]}, {"Citation": "Shahla K, Ali A, Hossein M, et al. The efficacy of topical use of petroselinum crispum (parsley) versus hydroquinone cream for reduction of epidermal melasma: a randomized clinical trial. AJP. 2015;5(1):124\u2013125."}, {"Citation": "Debbie M, Palmer DO, Jennifer SK. A double blind, randomized, controlled clinical trial evaluating the efficacy and tolerance of a novel phenolic antioxidant skin care system containing Coffea arabica and concentrated fruit and vegetable extracts. J Drugs Dermatol. 2010;9(12):1480\u20131487.", "ArticleIdList": ["21120255"]}, {"Citation": "Buggiani G, Tsampau D, Hercogov\u00e0 J, et al. Clinical efficacy of a novel topical formulation for vitiligo: compared evaluation of different treatment modalities in 149 patients. Dermatol Ther. 2012;25(5):472\u2013476. doi:10.1111/j.1529-8019.2012.01484.x", "ArticleIdList": ["10.1111/j.1529-8019.2012.01484.x", "23046028"]}, {"Citation": "Hussain I, Hussain I, Manan A, et al. Fabrication of anti-vitiligo ointment containing Psoralea corylifolia: in vitro and in vivo characterization. Drug Des Devel Ther. 2016;10:3805\u20133816. doi:10.2147/DDDT.S114328", "ArticleIdList": ["10.2147/DDDT.S114328", "PMC5125804", "27920496"]}, {"Citation": "Orest S, Neill S, Anna T, et al. Ginkgo Biloba for the treatment of vitiligo Vulgaris: an open label pilot clinical trial. BMC Complement Altern Med. 2011;21:1\u20139.", "ArticleIdList": ["PMC3065445", "21406109"]}, {"Citation": "Ahmed R, Abu R, Noor MA, et al. Evaluation of standardized extract of Ginkgo Biloba in vitiligo remedy. Asian J Pharm Clin Res. 2013;6(5):127\u2013130."}, {"Citation": "Parasad P. Effectiveness of oral Ginkgo biloba in treating limited, slowly spreading vitiligo. Clin Exp Dermatol. 2003;28:285\u2013287. doi:10.1046/j.1365-2230.2003.01207.x", "ArticleIdList": ["10.1046/j.1365-2230.2003.01207.x", "12780716"]}, {"Citation": "Jun Y, Atsushi S, Shoichi T, et al. Oral intake of proanthocyanidin-rich extract from grape seeds improves chloasma. Phytother Res. 2004;18:895\u2013899. doi:10.1002/ptr.1537", "ArticleIdList": ["10.1002/ptr.1537", "15597304"]}, {"Citation": "Beidi KL, Usha Z, Chopra CL. Picrorhiza kurroa, an ayurvedic herb, may potentiate photochemotherapy in vitiligo. J Ethnopharmacol. 1989;27:347\u2013352. doi:10.1016/0378-8741(89)90009-3", "ArticleIdList": ["10.1016/0378-8741(89)90009-3", "2615440"]}, {"Citation": "Glen A, Nino C, Ailynne V, et al. Maria Jasmin Jamora MD. A comparative study of the safety and efficacy of 75% Mulberry (Morus alba) Extract oil versus placebo as a topical treatment for melasma: a randomized, single-blind, placebo-controlled Trial. J Drugs Dermatol. 2011;10(9):1025\u20131031.", "ArticleIdList": ["22052272"]}, {"Citation": "Ammar M, Ahmed M, Isha L, et al. randomized, double-blinded, placebo controlled trial of oral Polypodium leucotomos extract as an adjunct to sunscreen in the treatment of melasma. JAMA Dermatol. 2013;149(8):981\u2013983. doi:10.1001/jamadermatol.2013.4294", "ArticleIdList": ["10.1001/jamadermatol.2013.4294", "23740292"]}, {"Citation": "Lucy K, Martin M. A randomized double-blind placebo controlled study evaluating the effectiveness and tolerability of oral polypodium leucotomos in patients wit melasma. J Am Acad Dermatol. 2012;Ab21:4630."}, {"Citation": "Eduardo R, Pedro J, Elena H, et al. Systemic Immunomodulatory effects of Polypodium leucotomos as an adjuvant to PUVA therapy in generalized vitiligo: a pilot study. J Dermatol Sci. 2006;41:213\u2013216. doi:10.1016/j.jdermsci.2005.12.006", "ArticleIdList": ["10.1016/j.jdermsci.2005.12.006", "16423508"]}, {"Citation": "Martiza A, Middelkamp H, Madhu A, et al. Orally administered Polypodium leucotomos extract decreases psoralen UVA induced phototoxicity, pigmentation, and damage of human skin. J Am Acad Dermatol. 2004;50:41\u201349. doi:10.1016/S0190-9622(03)02732-4", "ArticleIdList": ["10.1016/S0190-9622(03)02732-4", "14699363"]}, {"Citation": "Mark S, Nestor BD, Nicole S. Safety and efficacy of oral Polypodium leucotomos extract in healthy adult subjects. J Clin Aesthet Dermatol. 2015;8(2):19\u201323.", "ArticleIdList": ["PMC4345929", "25741399"]}, {"Citation": "Colucci R, Dragoni F, Conti R. Evaluation of an oral supplement containing Phyllanthus emblica fruit extracts, vitamin E, and carotenoids in vitiligo treatment. Dermatolog Treat. 2015;28:17\u201321. doi:10.1111/dth.12172", "ArticleIdList": ["10.1111/dth.12172", "25285994"]}, {"Citation": "Adilson C, Tatiana C, Juliana M. Association of emblica, licorice and belides as an alternative to hydroquinone in the clinical treatment of melasma. An Bras Dermatol. 2010;85(5):613\u2013620. doi:10.1590/S0365-05962010000500003", "ArticleIdList": ["10.1590/S0365-05962010000500003", "21152784"]}, {"Citation": "Ni Z, Mu Y, Gulati O. Treatment of melasma with pycnogenol. Phytother Res. 2002;16:567\u2013571. doi:10.1002/ptr.1085", "ArticleIdList": ["10.1002/ptr.1085", "12237816"]}, {"Citation": "Mendoza CG. A randomized, double blind, placebo-controlled clinical trial on the efficacy of 3% Rumex occidentalis cream versus 4% hydroquinone cream in the treatment of melasma among Filipinos. Int J Dermatol. 2014;53:1412\u20131416. doi:10.1111/ijd.12690", "ArticleIdList": ["10.1111/ijd.12690", "25265986"]}, {"Citation": "Morag M, Nawrot J, Siatkowski I, et al. A double-blind, placebo-controlled randomized trial of Serratulae quinquefoliae folium, a new source of \u03b2 -arbutin, in selected skin hyperpigmentations. J Cosmet Dermatol. 2015;14(3):185\u2013190. doi:10.1111/jocd.12147", "ArticleIdList": ["10.1111/jocd.12147", "26119285"]}, {"Citation": "Leeuw JD, Assen YJ, Van N, et al. Treatment of vitiligo with khellin liposomes, ultraviolet light and blister roof transplantation. J Eur Acad Dermatol Venereol. 2011;25(1):74\u201381. doi:10.1111/j.1468-3083.2010.03701.x", "ArticleIdList": ["10.1111/j.1468-3083.2010.03701.x", "20477914"]}, {"Citation": "Saraceno R, Steven P. Nistico, monochromatic excimer light 308 nm in monotherapy and combined with topical khellin 4% in the treatment of vitiligo: a controlled study. Dermatolog Treat. 2009;25:391\u2013394. doi:10.1111/j.1529-8019.2009.01252.x", "ArticleIdList": ["10.1111/j.1529-8019.2009.01252.x", "19580584"]}, {"Citation": "Valkova TC. Treatment of vitiligo with local Khellin and UVA: comparison with systemic PUVA. Clin Exp Dermatol. 2003;29:180\u2013184. doi:10.1111/j.1365-2230.2004.01462.x", "ArticleIdList": ["10.1111/j.1365-2230.2004.01462.x", "14987278"]}, {"Citation": "Orecchia G, Sangalli M, Gazzaniga A, Giordano F. Topical photochemotherapy of vitiligo with a new Khellin formulation. J Dermatolog Treat. 1998;9(2):65\u201369. doi:10.3109/09546639809161375", "ArticleIdList": ["10.3109/09546639809161375"]}, {"Citation": "Procaccini E, Riccio G, Monfrecola G. Ineffectiveness of topical Khellin in photochemotherapy of vitiligo. J Dermatolog Treat. 1995;6(2):117\u2013120. doi:10.3109/09546639509097164", "ArticleIdList": ["10.3109/09546639509097164"]}, {"Citation": "Bernhard O, Adrian T, Herbert H. Treatment of vitiligo with Khellin and Ultraviolet A. J Am Acad Dermatol. 1988;18:693\u2013701. doi:10.1016/S0190-9622(88)70092-4", "ArticleIdList": ["10.1016/S0190-9622(88)70092-4", "3270995"]}, {"Citation": "Mofty M, Bosseila M, Mashaly HM, et al. Broadband ultraviolet A vs. psoralen ultraviolet A in the treatment of vitiligo: a randomized controlled trial. Clin Exp Dermatol. 2013;38(8):830\u2013835. doi:10.1111/ced.12099", "ArticleIdList": ["10.1111/ced.12099", "23551324"]}, {"Citation": "Shivani B, Bijaylaxmi S, Vijay G. Psoralen-narrowband UVB phototherapy for the treatment of vitiligo in comparison to narrowband UVB alone. Photodermatol Photoimmunol Photomed. 2013;29:311\u2013317. doi:10.1111/phpp.12072", "ArticleIdList": ["10.1111/phpp.12072", "24118425"]}, {"Citation": "Ranjeeta S, Sudha A, Tapan K. Systemic PUVA vs narrowband UVB in the treatment of Vitiligo: a randomized controlled Study. Int J Dermatol. 2012;51:1107\u20131115. doi:10.1111/j.1365-4632.2011.05454.x", "ArticleIdList": ["10.1111/j.1365-4632.2011.05454.x", "22909369"]}, {"Citation": "Yones SS, Palmer RA, Garibaldinos TM, Hawk JL. Randomized double-blind trial of treatment of Vitiligo: efficacy of psoralen\u2013UV-A therapy vs narrowband\u2013UV-B therapy. Arch Dermatol. 2007;143:578\u2013584. doi:10.1001/archderm.143.5.578", "ArticleIdList": ["10.1001/archderm.143.5.578", "17519217"]}, {"Citation": "Bhatnagar A, Kanwar AJ, Parsad D, De D. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study. J Eur Acad Dermatol Venereol. 2007;21(10):1381\u20131385. doi:10.1111/j.1468-3083.2007.02283.x", "ArticleIdList": ["10.1111/j.1468-3083.2007.02283.x", "17958845"]}, {"Citation": "Ermis A. Is the efficacy of Psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study. Br J Dermatol. 2001;145:472\u2013475. doi:10.1046/j.1365-2133.2001.04286.x", "ArticleIdList": ["10.1046/j.1365-2133.2001.04286.x", "11531839"]}, {"Citation": "Ameen E, Chu A. Topical calcipotriol as monotherapy and in combination with psoralen plus ultraviolet A in the treatment of vitiligo. Br J Dermatol. 2001;145:476\u2013479. doi:10.1046/j.1365-2133.2001.04381.x", "ArticleIdList": ["10.1046/j.1365-2133.2001.04381.x", "11531840"]}, {"Citation": "Parsad D, Saini R, Verma N. Combination of PUVAsol and topical calcipotriol in Vitiligo. Dermatology. 1998;197(2):167\u2013170. doi:10.1159/000017991", "ArticleIdList": ["10.1159/000017991", "9732168"]}, {"Citation": "Parasad D, Roma P, Sunil D, et al. Clinical study of repigmentation patterns with different treatment modalities and their correlation with speed and stability of repigmentation in 352 vitiliginous patches. J Am Acad Dermatol. 2004;50(1):63\u201367. doi:10.1016/S0190-9622(03)00786-2", "ArticleIdList": ["10.1016/S0190-9622(03)00786-2", "14699367"]}, {"Citation": "Wiete W, Ludmila N. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A. Arch Dermatol. 1997;133:1525\u20131528. doi:10.1001/archderm.1997.03890480045006", "ArticleIdList": ["10.1001/archderm.1997.03890480045006", "9420536"]}, {"Citation": "Mofty A, Hussein E. Clinical study of a new preparation of 8-methoxypsoralen in photochemotherapy. Int J Dermatol. 1994;33(8):588\u2013593. doi:10.1111/j.1365-4362.1994.tb02904.x", "ArticleIdList": ["10.1111/j.1365-4362.1994.tb02904.x", "7960360"]}, {"Citation": "Africk J, Fulton J. Treatment of vitiligo with topical trimethylpsoralen and sunlight. Br J Dermatol. 1989;84:151\u2013156. doi:10.1111/j.1365-2133.1971.tb06858.x", "ArticleIdList": ["10.1111/j.1365-2133.1971.tb06858.x", "5548464"]}, {"Citation": "Sehgal. A comparative clinical evaluation of trimethylpsoralen, psoralen and 8-methoxypsoralen in treating vitiligo. Int J Dermatol. 1975;14:205\u2013208. doi:10.1111/ijd.1975.14.3.205", "ArticleIdList": ["10.1111/ijd.1975.14.3.205", "1126780"]}, {"Citation": "Mofty AME, Nada MM. On the treatment of vitiligo. Int J Dermatol. 1971;10(4):262\u2013266. doi:10.1111/j.1365-4362.1971.tb01709.x", "ArticleIdList": ["10.1111/j.1365-4362.1971.tb01709.x", "5114016"]}, {"Citation": "Dushet P, Schwarz T, Pusch M, Gshnait F. Marked increase of liver transaminases after khellin and UVA therapy. J Am Acad Dermatol. 1989;21(3):592\u2013593. doi:10.1016/S0190-9622(89)80248-8", "ArticleIdList": ["10.1016/S0190-9622(89)80248-8", "2778124"]}, {"Citation": "Kreuter A, Gambichier AA, Jansen T. Localized vitiligo successfully treated with cream-psoralen + Ultraviolet A. J Eur Acad Dermatol Venereol. 2001;15:357\u2013358.", "ArticleIdList": ["11730053"]}, {"Citation": "Maurice CJ. The dangers of herbalism. BMJ. 1989;299:1204. doi:10.1136/bmj.299.6709.1204", "ArticleIdList": ["10.1136/bmj.299.6709.1204", "PMC1838044", "2513051"]}, {"Citation": "David W, Mai CO. Childhood vitiligo successfully treated with Bath PUVA. Pediatr Dermatol. 1998;15(1):53\u201355. doi:10.1046/j.1525-1470.1998.1998015053.x", "ArticleIdList": ["10.1046/j.1525-1470.1998.1998015053.x", "9496807"]}, {"Citation": "Zouhir D. Successful treatment of facial vitiligo with honey bee, Allium cepa and Avena sativa combined to sun light exposure: a case clinical trial. Int J Pharm Clin Res. 2015;7(1):9\u201314."}, {"Citation": "Rigmor M, Jette H. Methoxsalen and multiple basal cell carcinomas. Arch Dermatol. 1976;112:1613\u20131614. doi:10.1001/archderm.1976.01630350079027", "ArticleIdList": ["10.1001/archderm.1976.01630350079027", "984871"]}, {"Citation": "Deborah AS, Stwart M. A rare case of acute hepatitis induced bu use of Babchi seeds as an ayurvedic remedy for vitiligo. BMJ Case Rep. 2014;1\u20133. doi:10.1136/bcr-2013-200958", "ArticleIdList": ["10.1136/bcr-2013-200958", "PMC4127755", "25103314"]}, {"Citation": "Abdel N, Okby WM. Psoralen plus ultraviolet A irradiation-induced lentigines arising in vitiligo: involvement of vitiliginous and normal appearing skin. Clinical Dermatol. 2004;29:380\u2013382.", "ArticleIdList": ["15245535"]}, {"Citation": "World Health Organization.TM.VigiAccessAvailable from:\nwww.vigiaccess.org. Accessed December9, 2017."}, {"Citation": "Donata SR, Kesavan M, Austin KS, Rajagopalan K, Kuttan R. Clinical trial of certain ayurvedic medicines indicated in vitiligo. Anc Sci Life. 1990;9:202\u2013206.", "ArticleIdList": ["PMC3331338", "22557698"]}, {"Citation": "Psoralea corylifolia. Available from:\nhttp://examine.com/supplements/Psoralea+Corylifolia/summary2-1. Accessed 22July 2013."}, {"Citation": "New WB. Manual of Homeopathic Materia Medica and Repertory. 9th ed. New Delhi: B. Jain Publishers Pvt. Ltd; 2002:11\u201329."}, {"Citation": "Stephen B, Harley G, Amy P, et al. Spontaneous bleeding associated with Ginkgo biloba. A case report and systematic review of the literature. J Gen Intern Med. 2005;20:657\u2013661. doi:10.1007/s11606-005-0114-4", "ArticleIdList": ["10.1007/s11606-005-0114-4", "PMC1490168", "16050865"]}, {"Citation": "Ansari R, Aswal B, Chander R, et al. Hepatoprotective activity of kutin- the iridoid glycoside mixture of Picrorhiza Kurroa. Indian J Med Res. 1988;87:401\u2013404.", "ArticleIdList": ["3049327"]}, {"Citation": "Handa S, Sharma A, Chakraborty K. Natural products and plants as liver protecting drugs. Fitoterapia. 1986;58:307\u2013351."}, {"Citation": "Middelkamp-Hup MA, Pathak MA, Parrado C, et al. Oral Polypodium leucotomos extract decreases ultraviolet-induced damage of human skin. J Am Acad Dermatol. 2004;51:910\u2013918. doi:10.1016/j.jaad.2004.06.027", "ArticleIdList": ["10.1016/j.jaad.2004.06.027", "15583582"]}, {"Citation": "Gonzales S, Pathak MA, Cuevas J, Villarrubia VG, Fitzpatrick TB. Topical or oral administration with an extract of Polypodium leucotomos prevents acute sunburn and-psoralen induced phototoxic reactions as well as depletion of Langerhans cells in human skin. Photodermatol Photoimmunol Photomed. 1997;13:50\u201360. doi:10.1111/j.1600-0781.1997.tb00108.x", "ArticleIdList": ["10.1111/j.1600-0781.1997.tb00108.x", "9361129"]}, {"Citation": "Anrep GV, Kenawy MR, Barsoum GS. The coronary vasodilator action of khellin. Am Heart J. 1949;37:531\u2013542. doi:10.1016/0002-8703(49)91131-X", "ArticleIdList": ["10.1016/0002-8703(49)91131-X", "18124896"]}, {"Citation": "Herbert Hbnigsmann MD, Bernhard Ortel MD, Tanew A. Reply. J Am Acad Dermatol. 1989;21(3):593\u2013594. doi:10.1016/S0190-9622(89)80249-X", "ArticleIdList": ["10.1016/S0190-9622(89)80249-X"]}, {"Citation": "Armbrust CA, Levine SA. The treatment of angina pectoris with a preparation of khelIin. Am J Med Sci. 1950;220:127. doi:10.1097/00000441-195008000-00002", "ArticleIdList": ["10.1097/00000441-195008000-00002", "15432447"]}, {"Citation": "Hofer A, Karl H, Wolf P. Long-term results in the treatment of vitiligo with oral khellin plus UVA. Eur J Dermatol. 2001;11:225\u2013229.", "ArticleIdList": ["11358729"]}, {"Citation": "Morliere P, Honigsmann H, Averbeck D. Phototherapeutic, photobiologic and photosensitizing properties of Khellin. J Invest Dermatol. 1988;90:720\u2013724. doi:10.1111/1523-1747.ep13083852", "ArticleIdList": ["10.1111/1523-1747.ep13083852", "3283251"]}, {"Citation": "Ortonne J. Psoralen therapy in vitiligo. Clin Dermatol. 1989;7(2):120\u2013135. doi:10.1016/0738-081X(89)90062-X", "ArticleIdList": ["10.1016/0738-081X(89)90062-X", "2667737"]}, {"Citation": "Said HM. Hamdard pharmacographica. Indica. 1972;XV(Special Issue):412\u2013413."}, {"Citation": "Leroy D, Dompmartin A, Dubreuil A, et al. Cryotherapy of PUVA lentigines. Br J Dermatol. 1996;135:988\u2013990. doi:10.1046/j.1365-2133.1996.d01-1108.x", "ArticleIdList": ["10.1046/j.1365-2133.1996.d01-1108.x", "8977725"]}, {"Citation": "Collins P, Rogers S. Bath water compared with oral delivery of 8-methoxypsoralen PUVA for chronic plaque type psoriasis. Br J Dermatol. 1992;127:392\u2013395. doi:10.1111/j.1365-2133.1992.tb00460.x", "ArticleIdList": ["10.1111/j.1365-2133.1992.tb00460.x", "1419760"]}, {"Citation": "Ortel B, Perl S, Kinaciyan T, et al. Comparison of narrow-band (311 nm). UVB and broad band UVA after oral or bath water 8-methoxypsoralen in the treatment of Psoriasis. J Am Acad Dermatol. 1993;29:736\u2013740. doi:10.1016/0190-9622(93)70239-P", "ArticleIdList": ["10.1016/0190-9622(93)70239-P", "8227546"]}, {"Citation": "Forton F, Germaux MA, Brasseur T, et al. Demodicosis and rosacea: epidemiology and significance in daily dermatologic practice. J Am Acad Dermatol. 2005;52:74\u201387. doi:10.1016/j.jaad.2004.05.034", "ArticleIdList": ["10.1016/j.jaad.2004.05.034", "15627084"]}, {"Citation": "mutalik SD, Pethe SV, Nikam BP, et al. Facial frictional melanosis in Indian patients: defining the entity. Clin Dermatol Rev. 2019;3(1):78\u201383. doi:10.4103/CDR.CDR_6_18", "ArticleIdList": ["10.4103/CDR.CDR_6_18"]}, {"Citation": "Shekhaar N, Radhakrishnan PK. Demodex induced facial frictional melanoses. Aust J Dermatol. 2020;61(4):e490\u2013e492.", "ArticleIdList": ["32686077"]}, {"Citation": "Tian Y, Li CP, Deng Y. Anti-mite activity and skin safety of Herbal taraxaci extract for Demodex folliculorum. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2007;25(2):133\u2013136.", "ArticleIdList": ["17633825"]}, {"Citation": "Tian Y, Li CP. Anti-mite activities of 25 kinds of traditional Chinese medicines for Demodex folliculorum]. Zhong Yao Cai. 2006;10:1013\u20131015.", "ArticleIdList": ["17326398"]}, {"Citation": "Faas L, Venkatasamy R, RC Hider, AR Young, Soumyanath A. In vivo evaluation of piperine and synthetic analogues as potential treatments for vitiligo using a sparsely pigmented mouse model. Br J Dermatol. 2008;158:941\u2013950. doi:10.1111/j.1365-2133.2008.08464.x", "ArticleIdList": ["10.1111/j.1365-2133.2008.08464.x", "18284389"]}, {"Citation": "Mih\u0103il\u0103 B, Dinic\u0103 RM, Tatu A, et al. New insights in vitiligo treatments using bioactive compounds from Piper nigrum. Exp Ther Med. 2019;17(2):1039\u20131044. doi:10.3892/etm.2018.6977", "ArticleIdList": ["10.3892/etm.2018.6977", "PMC6327422", "30679971"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "12", "Day": "20"}, {"Year": "2021", "Month": "1", "Day": "24"}, {"Year": "2021", "Month": "4", "Day": "1", "Hour": "6", "Minute": "23"}, {"Year": "2021", "Month": "4", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "4", "Day": "2", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "3", "Day": "23"}], "PublicationStatus": "epublish", "ArticleIdList": ["33790609", "PMC8001124", "10.2147/CCID.S298342", "298342"]}}], "PubmedBookArticle": []}